Previously, we generated a transgenic mouse line expressing a truncated form of human FUS (1–359) that induces FUS-proteinopathy accompanied by motor neuron death and ALS clinical patterns (Shelkovnikova et al., 2013). This evidence concerns the gene FUS and amyotrophic lateral sclerosis.